Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply. [electronic resource]
Producer: 20190729Description: 1423-1424 p. digitalISSN:- 1365-2036
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.